应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HAE 美国血液技术
盘后交易 04-26 18:58:38 EDT
90.99
+3.33
+3.80%
盘后
90.99
+0.00
0.00%
16:20 EDT
最高
91.58
最低
87.49
成交量
74.90万
今开
87.49
昨收
87.66
日振幅
4.67%
总市值
46.21亿
流通市值
45.84亿
总股本
5,079万
成交额
6,760万
换手率
1.49%
流通股本
5,037万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至105.00美元。
智通财经 · 04-12
Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至105.00美元。
百度健康上线罕见病中心,法布雷病及HAE患者可开展线上自筛
美通社 · 02-29
百度健康上线罕见病中心,法布雷病及HAE患者可开展线上自筛
更新版 1-KalVista 在遗传病后期试验中达到主要目标
Reuters · 02-13
更新版 1-KalVista 在遗传病后期试验中达到主要目标
加载更多
公司概况
公司名称:
美国血液技术
所属市场:
NYSE
上市日期:
--
主营业务:
Haemonetics Corporation成立于1971年,是一个全球性医疗设备公司,致力于为客户提供创新的血液管理解决方案——血浆来源收集者,采血机构和医院,在输血行业医疗设备系统方面有着强大的品牌优势,为客户提供解决方案的同时还提供信息技术平台和增值服务,其解决方案帮助患者改善临床结果,并提高血液中的供应链效率。
发行价格:
--
{"stockData":{"symbol":"HAE","market":"US","secType":"STK","nameCN":"美国血液技术","latestPrice":90.99,"timestamp":1714161600000,"preClose":87.66,"halted":0,"volume":749023,"hourTrading":{"tag":"盘后","latestPrice":90.99,"preClose":90.99,"latestTime":"16:20 EDT","volume":17472,"amount":1589777.2799999998,"timestamp":1714162801023},"delay":0,"floatShares":50374454,"shares":50786117,"eps":2.460205,"marketStatus":"盘后交易","marketStatusCode":4,"change":3.33,"latestTime":"04-26 18:58:38 EDT","open":87.49,"high":91.58,"low":87.49,"amount":67595415.84994,"amplitude":0.046658,"askPrice":91.37,"askSize":99,"bidPrice":90.62,"bidSize":99,"shortable":3,"etf":0,"ttmEps":2.460205,"exchange":"NYSE","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714176000000},"adr":0,"listingDate":673761600000,"adjPreClose":87.66,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":90.99,"preClose":90.99,"latestTime":"16:20 EDT","volume":17472,"amount":1589777.2799999998,"timestamp":1714162801023},"volumeRatio":1.743163},"requestUrl":"/m/hq/s/HAE?invite=TIGER026","defaultTab":"news","newsList":[{"id":"2426739480","title":"Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至105.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426739480","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426739480?lang=zh_cn&edition=full","pubTime":"2024-04-12 22:55","pubTimestamp":1712933721,"startTime":"0","endTime":"0","summary":"Barrington Research:维持Haemonetics(HAE.US)评级,由优于大市调整至优于大市评级, 目标价由105.00美元调整至105.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412225526876fb12b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412225526876fb12b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415259968","title":"百度健康上线罕见病中心,法布雷病及HAE患者可开展线上自筛","url":"https://stock-news.laohu8.com/highlight/detail?id=2415259968","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2415259968?lang=zh_cn&edition=full","pubTime":"2024-02-29 16:11","pubTimestamp":1709194260,"startTime":"0","endTime":"0","summary":"由健康管理平台百度健康携手中国罕见病联盟共建的\"罕见病中心\"正式升级上线。在我国,法布雷病的总体筛查诊断率仅为3%。延迟诊断会增加HAE患者因喉部水肿发作导致的死亡风险。此次百度健康上线\"罕见病中心\"将为这些疾病提供科普和自筛指引,一方面提升大众对于法布雷病及HAE的疾病认知,另一方面帮助公众在面对疾病威胁时能够做到\"早筛查、早发现,早治疗\",从而提高诊断意识。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4349121_ZH49121_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411355969","title":"更新版 1-KalVista 在遗传病后期试验中达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2411355969","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411355969?lang=zh_cn&edition=full","pubTime":"2024-02-13 20:10","pubTimestamp":1707826232,"startTime":"0","endTime":"0","summary":" 路透社2月13日 - KalVista Pharmaceuticals 周二称,其治疗一种遗传性疾病的疗法在一项后期试验中达到了主要目标,这种疾病会导致皮下和身体其他部位迅速肿胀。这种名为sebetralstat的疗法显示,遗传性血管性水肿 患者开始缓解症状的速度明显快于安慰剂。使用低剂量的sebetralstat,症状开始缓解的中位时间为1.61小时,而使用安慰剂则为6.72小时。Sebetralstat在136名成人和青少年HAE患者中进行了测试,HAE是一种因缺乏某种名为C1-抑制因子的蛋白质或其功能障碍而引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.haemonetics.com","stockEarnings":[{"period":"1week","weight":0.0503},{"period":"1month","weight":0.0737},{"period":"3month","weight":0.0782},{"period":"6month","weight":0.0368},{"period":"1year","weight":0.0647},{"period":"ytd","weight":0.0251}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Haemonetics Corporation成立于1971年,是一个全球性医疗设备公司,致力于为客户提供创新的血液管理解决方案——血浆来源收集者,采血机构和医院,在输血行业医疗设备系统方面有着强大的品牌优势,为客户提供解决方案的同时还提供信息技术平台和增值服务,其解决方案帮助患者改善临床结果,并提高血液中的供应链效率。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.01405},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.011877},{"month":3,"riseRate":0.69697,"avgChangeRate":0.022898},{"month":4,"riseRate":0.484848,"avgChangeRate":-0.026647},{"month":5,"riseRate":0.53125,"avgChangeRate":0.019103},{"month":6,"riseRate":0.606061,"avgChangeRate":0.020417},{"month":7,"riseRate":0.666667,"avgChangeRate":0.016689},{"month":8,"riseRate":0.757576,"avgChangeRate":0.035488},{"month":9,"riseRate":0.515152,"avgChangeRate":0.015262},{"month":10,"riseRate":0.515152,"avgChangeRate":-0.002825},{"month":11,"riseRate":0.515152,"avgChangeRate":0.023869},{"month":12,"riseRate":0.606061,"avgChangeRate":0.028114}],"exchange":"NYSE","name":"美国血液技术","nameEN":"Haemonetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美国血液技术(HAE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美国血液技术,HAE,美国血液技术股票,美国血液技术股票老虎,美国血液技术股票老虎国际,美国血液技术行情,美国血液技术股票行情,美国血液技术股价,美国血液技术股市,美国血液技术股票价格,美国血液技术股票交易,美国血液技术股票购买,美国血液技术股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美国血液技术(HAE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美国血液技术(HAE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}